Morning After
Product Images NDC 69953-514

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Morning After (NDC 69953-514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rapha Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Fdafinal)

This is a morning-after pill used to reduce the chance of pregnancy after unprotected sex. It is most effective when taken within 72 hours (3 days) after unprotected sex. The pill should not be taken during pregnancy and may cause allergic reactions or certain side effects. This medication should not be used in place of regular birth control. For more information and directions on how to take the morning-after pill, visit www.buymorningafter.com.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.